<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">4325</id>
  <title>T3D4271</title>
  <common-name>Gamma-Glutamylcysteine</common-name>
  <description>G-Glutamylcysteine is a product of enzyme glutamate-cysteine ligase [EC 6.3.2.2] and a substrate of enzyme glutathione synthase [EC 6.3.2.3] in glutamate metabolism pathway (KEGG).</description>
  <cas>636-58-8</cas>
  <pubchem-id>123938</pubchem-id>
  <chemical-formula>C8H14N2O5S</chemical-formula>
  <weight nil="true"/>
  <appearance>White powder.</appearance>
  <melting-point></melting-point>
  <boiling-point></boiling-point>
  <density nil="true"/>
  <solubility></solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>This is an endogenously produced metabolite found in the human body. It is used in metabolic reactions, catabolic reactions or waste generation.</use-source>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2014-08-29T06:11:23Z</created-at>
  <updated-at type="dateTime">2026-04-02T23:56:01Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id>C00669</kegg-compound-id>
  <omim-id nil="true"/>
  <chebi-id>17515</chebi-id>
  <biocyc-id>L-GAMMA-GLUTAMYLCYSTEINE</biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB03408</drugbank-id>
  <pdb-id>3GC</pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>N[C@@H](CCC(=O)N[C@@H](CS)C(O)=O)C(O)=O</moldb-smiles>
  <moldb-formula>C8H14N2O5S</moldb-formula>
  <moldb-inchi>InChI=1S/C8H14N2O5S/c9-4(7(12)13)1-2-6(11)10-5(3-16)8(14)15/h4-5,16H,1-3,9H2,(H,10,11)(H,12,13)(H,14,15)/t4-,5-/m0/s1</moldb-inchi>
  <moldb-inchikey>RITKHVBHSGLULN-WHFBIAKZSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">250.272</moldb-average-mass>
  <moldb-mono-mass type="decimal">250.062342258</moldb-mono-mass>
  <origin>Endogenous</origin>
  <state>Solid</state>
  <logp nil="true"/>
  <hmdb-id>HMDB01049</hmdb-id>
  <chembl-id>CHEMBL460831</chembl-id>
  <chemspider-id>110467</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>&lt;p&gt;Hiroaki Nishiuchi, &amp;#8220;Method for producing gamma-glutamylcysteine.&amp;#8221; U.S. Patent US20030124684, issued July 03, 2003.&lt;/p&gt;</synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM003231</chemdb-id>
  <dsstox-id>DTXSID90212978</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00014839</susdat-id>
  <iupac>(2S)-2-amino-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid</iupac>
</compound>
